Helicobacter pylori infection, its laboratory diagnosis, and antimicrobial resistance: a perspective of clinical relevance

S Ansari, Y Yamaoka - Clinical microbiology reviews, 2022 - Am Soc Microbiol
Despite the recent decrease in overall prevalence of Helicobacter pylori infection, morbidity
and mortality rates associated with gastric cancer remain high. The antimicrobial resistance …

Trends in Helicobacter pylori resistance to clarithromycin: from phenotypic to genomic approaches

AT Marques, JMB Vítor, A Santos… - Microbial …, 2020 - microbiologyresearch.org
For a long time Helicobacter pylori infections have been treated using the macrolide
antibiotic, clarithromycin. Clarithromycin resistance is increasing worldwide and is the most …

The prevalence of clarithromycin-resistant Helicobacter pylori isolates: a systematic review and meta-analysis

M Sholeh, S Khoshnood, T Azimi, J Mohamadi… - PeerJ, 2023 - peerj.com
Background Knowledge of global clarithromycin (CLA)-resistant rates of Helicobacter pylori
(H. pylori) is crucial for decision of the most appropriate eradication therapies with good …

Molecular detection of Helicobacter pylori and clarithromycin resistance in gastric biopsies: a prospective evaluation of RIDA®GENE Helicobacter pylori assay

B Van den Poel, S Gils, I Micalessi, S Carton… - Acta Clinica …, 2021 - Taylor & Francis
ABSTRACT Background: Empirical treatment of Helicobacter pylo ri (HP) depends on the
local prevalence of clarithromycin resistance but data are lacking and culturing of HP is time …

Helicobacter pylori heteroresistance to clarithromycin in adults—New data by in situ detection and improved concept

É Kocsmár, I Kocsmár, GM Buzás, I Szirtes… - …, 2020 - Wiley Online Library
Abstract Background Clarithromycin (Cla) heteroresistance of Helicobacter pylori (H pylori)
infections is commonly assessed by comparing the resistance status of antrum and corpus …

Detection of Helicobacter pylori by invasive tests in adult dyspeptic patientsand antibacterial resistance to six antibiotics, including rifampicin in Turkey …

M Akar, F Aydin, T Kayman, S Abay… - Turkish Journal of …, 2021 - journals.tubitak.gov.tr
Background/aim: The prevalence of Helicobacter pylori is reported to be roughly 80% in
Turkey, and only very few culture-based studies are available on antibacterial resistance in …

Evidence of Helicobacter pylori heterogeneity in human stomachs by susceptibility testing and characterization of mutations in drug-resistant isolates

JM Islam, Y Yano, A Okamoto, R Matsuda… - Scientific Reports, 2024 - nature.com
Heterogeneity of Helicobacter pylori communities contributes to its pathogenicity and
diverse clinical outcomes. We conducted drug-susceptibility tests using four antibiotics …

Point Mutations at gyrA and gyrB Genes of Levofloxacin Resistant Helicobacter pylori Strains and Dual Resistance with Clarithromycin.

T Ziver-Sarp, P Yuksel-Mayda, S Saribas… - Clinical …, 2021 - search.ebscohost.com
Background: Spontaneous point mutations in genes encoding gyrA/B subunits of DNA
gyrase are responsible for fluoroquinolone resistance. We aimed to determine the …

A comprehensive study of Helicobacter pylori infection: molecular analysis, antibacterial susceptibility, and histopathological examination

F Buyuk, E Karakaya, M Akar, T Kayman… - Antonie van …, 2023 - Springer
Helicobacter pylori is a pathogen associated with gastroduodenal diseases. This study
aimed;(i) to investigate H. pylori presence by invasive tests in adult dyspeptic patients,(ii) to …

Treatment of Helicobacter pylori

EA Argueta, SF Moss - Current opinion in gastroenterology, 2019 - journals.lww.com
Treatment of Helicobacter pylori : Current Opinion in Gastroenterology Treatment of Helicobacter
pylori : Current Opinion in Gastroenterology Log in or Register Subscribe to journalSubscribe …